Clinical trial
Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
NCT01949766 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Transition From Buphenyl to RAVICTI for the Therapy of Byler Disease
- Lead sponsor
- University of Pittsburgh
- Phase
- Expanded access
- Overall status
- No longer available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
byler disease